Connect with us

Technology

Medical Gas Blenders Market to Grow by USD 582 Million (2024-2028), Driven by Aging Population and Chronic Disease Prevalence, with AI Impacting Market Trends – Technavio

Published

on

NEW YORK, Nov. 18, 2024 /PRNewswire/ — Report on how AI is redefining market landscape – The global medical gas blenders market size is estimated to grow by USD 582 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  5.42%  during the forecast period. Growing geriatric population and rising prevalence of chronic diseases is driving market growth, with a trend towards increasing use of respiratory gas blenders in nicus. However, stringent regulations on design and manufacturing of medical gas blenders  poses a challenge.Key market players include BioMed Devices, DEHAS Medical Systems GmbH, EKU Elektronik GmbH, ESAB Corp., Genstar Technologies Co. Inc., Guangdong Pigeon Medical Apparatus Co. Ltd., Halma Plc, HVS Oliver Hornla GmbH and Co. KG, Inspiration Healthcare Group Plc., MCQ Instruments, medin Medical Innovations GmbH, Ningbo David Medical Device Co. Ltd., Precision Medical Inc., S S Technomed P Ltd., Scanatron Technics AG, SHANGHAI AMCAREMED TECHNOLOGY Co. Ltd., TG Eakin Ltd., Weyer GmbH, WITT Gasetechnik GmbH and Co KG, and Zhengzhou Dison Instrument And Meter Co. Ltd..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Medical Gas Blenders Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 5.42%

Market growth 2024-2028

USD 582 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

5.04

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, Germany, China, Canada, and India

Key companies profiled

BioMed Devices, DEHAS Medical Systems GmbH, EKU Elektronik GmbH, ESAB Corp., Genstar Technologies Co. Inc., Guangdong Pigeon Medical Apparatus Co. Ltd., Halma Plc, HVS Oliver Hornla GmbH and Co. KG, Inspiration Healthcare Group Plc., MCQ Instruments, medin Medical Innovations GmbH, Ningbo David Medical Device Co. Ltd., Precision Medical Inc., S S Technomed P Ltd., Scanatron Technics AG, SHANGHAI AMCAREMED TECHNOLOGY Co. Ltd., TG Eakin Ltd., Weyer GmbH, WITT Gasetechnik GmbH and Co KG, and Zhengzhou Dison Instrument And Meter Co. Ltd.

Market Driver

The Medical Gas Blenders Market is experiencing significant growth due to the increasing number of surgical procedures, driven by diseases such as cancer in the elderly population. Anesthesia delivery machines require a precise flow of gases like oxygen and nitrous oxide for controlled anesthesia during surgery. Manual handling of gases is being replaced by automated handling and electronic control systems. The gas blending system, breathing system, ventilating system, and gas exhaust system are essential components of anesthetic devices. Oxygen, nitrous oxide, and other anesthesia gases are in high demand in hospitals and Ambulatory Surgical Centers. The VMR industry report provides forward-looking analysis and actionable data on gas flows, automated processing, and information management systems. Electronic gas mixing and gas monitoring ensure patient safety and respiratory monitoring. Self-inspection and data systems facilitate efficient gas source management. Outpatient surgeries, hernia operations, hip replacements, and knee replacements are common procedures that utilize medical gas blenders. Chronic conditions, heart surgeries, brain surgeries, lung surgeries, orthopaedic surgeries, gastrointestinal surgeries, inhalable anesthetics, intravenous anesthesia, and cosmetic procedures all require anesthetic devices. Emerging economies and the geriatric population’s adoption of these technologies are key growth drivers. Electric power is a critical factor in the functioning of these devices. The market pitches, business plans, presentations, and proposals highlight the importance of these trends in the medical industry. Sample VMR reports are available with discounts. 

The medical gas blenders market is witnessing significant growth due to the increasing demand for respiratory gas blenders in healthcare facilities. Neonates and infants, particularly those born prematurely, require additional oxygen to breathe properly after birth. The use of medical gas blenders ensures the delivery of precise oxygen mixtures to these patients, preventing potential brain damage or even death. Vendors, such as Ohio Medical, provide reliable and advanced gas blenders, including the NEO2 blend and low-flow models, designed for Neonatal Intensive Care Units (NICUs), ensuring accurate gas mixing for optimal patient care. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

Market Challenges

The Medical Gas Blenders Market faces several challenges in the healthcare industry. Diseases such as lung cancer, breast cancer, and prostate cancer require various surgical procedures, leading to an increased demand for anesthesia delivery machines and controlled anesthesia gases like oxygen and nitrous oxide. Manual handling of gases and knob adjustments in anesthetic devices can lead to errors. Electronic control and automated handling are solutions, but cost and self-inspection requirements add complexity. The VMR industry report highlights the importance of gas source, gas blending system, breathing system, ventilating system, gas exhaust system, data system, and electronic gas mixing for efficient gas monitoring and respiratory monitoring. Adoption of automated processing for air/oxygen and melting gas is increasing in Ambulatory Surgical Centers, Hospitals, and OECD countries. Emerging economies, geriatric population, and outpatient surgeries present growth opportunities. Electric power reliability and cost are key considerations. The market pitches, business plans, presentations, and proposals must address these challenges and provide actionable data and forward-looking analysis. Types of cancer, surgical admissions, and chronic conditions like heart and brain surgeries, hernia operations, hip replacement, and knee replacement drive demand for anesthesia gases and anesthetic devices. Inhalable anesthetics and intravenous anesthesia are alternatives. Medical practitioners and cosmetic procedures also utilize medical gas blenders. Medical tourism is a growing trend.Medical gas blenders are essential devices used in healthcare settings to deliver oxygen and heliox therapy, as well as life support in Intensive Care Units (ICUs) and emergency situations. The design and manufacturing of these devices are subject to stringent regulations to ensure safety and effectiveness. In Europe, medical gas blenders must comply with the Medical Device Directive (MDD), Directive 2007/47/EC, and Council Directive 93/42/EEC. Additionally, the oxygen used in medical gas blenders must meet regulatory standards, such as those set by the American National Standards Institute (ANSI) Z86 in the US. The production, handling, manufacturing, control, and distribution of medicinal oxygen are subject to rigorous regulations to maintain quality and safety.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This medical gas blenders market report extensively covers market segmentation by  

End-user 1.1 Hospitals1.2 Ambulatory surgical centers1.3 Pharmaceuticals1.4 Homecare settings1.5 Academic and research institutionsProduct 2.1 Dual flow2.2 Tube flowGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 Hospitals-  The hospital segment led the global medical gas blenders market in 2023, driven by the increasing patient population and subsequent demand for medical gas blenders. These devices are essential for delivering precise oxygen concentrations and flows to patients with hypoxic conditions. Medical gas blenders play a vital role in hospital care by enabling healthcare professionals to administer oxygen safely and accurately. With patient safety being a top priority, medical gas blenders are indispensable tools for ensuring optimal oxygen level monitoring. Consequently, the growing need for medical gas blenders in hospitals will fuel market expansion throughout the forecast period.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

The Medical Gas Blenders Market refers to the production and supply of devices used for blending and delivering anesthesia gases for surgical procedures. These gases, including oxygen and nitrous oxide, are essential for controlled anesthesia during surgery. Manual handling of gases using knobs on anesthesia delivery machines has evolved to electronic control and automated handling for improved precision and safety. Gas blending systems ensure accurate mixing of anesthesia gases from various gas sources. The breathing system delivers gases to the patient, while the ventilating system assists in breathing. Gas exhaust systems remove waste gases, and data systems monitor gas flow, oxygen levels, and patient vitals. Electronic gas mixing and gas monitoring ensure safe and efficient delivery of anesthesia gases. Regular self-inspection is crucial to maintain the functionality and safety of medical gas blenders.

Market Research Overview

The Medical Gas Blenders Market is a critical segment of the healthcare industry, supplying essential gases for various medical applications, including surgical procedures and anesthesia delivery. Diseases such as lung cancer, breast cancer, prostate cancer, and chronic conditions necessitate surgeries, leading to an increased demand for medical gases. Elderly populations in emerging economies and the growing number of outpatient surgeries in Ambulatory Surgical Centers and Hospitals are significant factors driving market growth. Medical Gas Blenders are used to blend and deliver anesthesia gases, including oxygen, nitrous oxide, and other anesthetic gases, in controlled quantities. These systems consist of a gas source, gas blending system, breathing system, ventilating system, gas exhaust system, data system, and electronic gas mixing with gas monitoring and respiratory monitoring. Manual and electronic control options are available, with automated handling and self-inspection features. The VMR Industry Report provides forward-looking analysis, actionable data, and pitches, business plans, presentations, and proposals for investors and industry professionals. The report covers gas flows, automated processing, air/oxygen, melting gas, and various types of surgeries, including hernia operations, hip replacements, knee replacements, heart surgeries, brain surgeries, lung surgeries, orthopaedic surgeries, gastrointestinal surgeries, inhalable anesthetics, intravenous anesthesia, and cosmetic procedures. The adoption of electronic control and automated handling in medical gas blenders is increasing due to their advantages over manual handling, including improved accuracy, safety, and efficiency. The market is expected to grow significantly due to the increasing number of surgical admissions, electric power usage, and the geriatric population’s rising healthcare needs. OECD statistics indicate that surgical procedures accounted for over 50% of all healthcare spending in 2019. In conclusion, the Medical Gas Blenders Market is a vital sector of the healthcare industry, providing essential gases for various medical applications, and its growth is driven by demographic and technological factors.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

End-userHospitalsAmbulatory Surgical CentersPharmaceuticalsHomecare SettingsAcademic And Research InstitutionsProductDual FlowTube FlowGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/medical-gas-blenders-market-to-grow-by-usd-582-million-2024-2028-driven-by-aging-population-and-chronic-disease-prevalence-with-ai-impacting-market-trends—technavio-302308022.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Sivers Semiconductors Signs CHIPS Act Contracts with the Northeast Microelectronics Coalition Hub

Published

on

By

The first half of $11.6M Microelectronics Commons funding for 5G/6G and Electronic Warfare chip technology to be received by January 2025

KISTA, Sweden, Jan. 13, 2025 /PRNewswire/ — Today, Sivers Semiconductors announced that it has successfully signed contracts for both the Electronic Warfare and 5G/6G chip development awards with the Northeast Microelectronics Coalition (NEMC) Hub through the U.S. CHIPS and Science Act. Funding is provided under the Microelectronics Commons program, executed through the Naval Surface Warfare Center Crane Division and the National Security Technology Accelerator (NSTXL).

These prestigious awards further validate Sivers’ wireless innovation as a critical enabler for mmWave technology adoption across markets. In these projects, Sivers will work with industry giants like BAE Systems, Raytheon, and Ericsson and lead the charge in commercializing RF and beamforming technology for defense and dual-use applications. 

Advance payment of roughly half of the first-year value of both programs is expected to occur by January 2025. If renewed over three years, under the discretion of future awards under the Microelectronics Commons program, the overall funding of both programs is expected to amount to approximately $30M.

“We are honored and grateful for these first two US CHIPS and Science Act funding awards and appreciate the support from the NEMC hub in helping find the right balance on associated contract structure and milestones,” said Vickram Vathulya, CEO of Sivers Semiconductors. “As we move forward with these critical portfolio projects, we remain committed to optimizing cash flow across all our development contracts, ensuring efficient working capital management while scaling our engagements.” 

“We’re proud to collaborate with our partners on advancing RF technology for 5G/6G FR3 and Electronic Warfare,” said Harish Krishnaswamy, Managing Director of the Wireless Division at Sivers Semiconductors. “FR3 represents the next leap in cellular innovation, merging the superior range of sub-6GHz with the high-speed capabilities of millimeter-waves. Additionally, we’re excited to broaden our portfolio with cutting-edge solutions for defense and electronic warfare, establishing a strong third pillar for our Wireless Division alongside SATCOM and 5G.”

“Sivers Semiconductors is a key partner as we work to expand microelectronics lab-to-fab capabilities across the Northeast,” said Mark Halfman, Director, NEMC Hub. “We are excited to collaborate on the development of critical technologies with opportunities for sustainable, positive impacts on our national security.”

About the NEMC Hub

The Northeast Microelectronics Coalition (NEMC) Hub is a network of 200+ organizations including commercial and defense companies, leading academic institutions, federally funded R&D centers (FFRDCs), and startups concentrated in eight Northeast states. Established in 2023, the Hub is one of eight regional Microelectronics Commons Hubs working to expand the nation’s global leadership in microelectronics and accelerate domestic semiconductor prototyping. The NEMC Hub is a division of the Massachusetts Technology Collaborative and was established with federal CHIPS and Science Act funding under the Microelectronics Commons program and executed through the Naval Surface Warfare Center (NSWC) Crane Division and the National Security Technology Accelerator (NSTXL). The Hub fosters a vibrant, connected microelectronics ecosystem to provide sustainable lab-to-fab enablement, boost education and workforce development, and spur new jobs. Learn more at  https://nemicroelectronics.org/

Contact
Vickram Vathulya
CEO, Sivers Semiconductors
Tel: +46 (0)8 703 68 00
Email: ir@sivers-semiconductors.com

About Sivers Semiconductors 

We are Critical Enablers of a Greener Data Economy with Energy Efficient Photonics & Wireless Solutions. Our differentiated high precision laser and RF beamformer technologies help our customers in key markets such as AI Data Centers, SATCOM, Defense and Telecom solve essential performance challenges while enabling a much greener footprint. Visit us at: www.sivers-semiconductors.com. (SIVE.ST)

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sivers-semiconductors/r/sivers-semiconductors-signs-chips-act-contracts-with-the-northeast-microelectronics-coalition-hub,c4090302

The following files are available for download:

https://mb.cision.com/Main/11695/4090302/3201494.pdf

MECommon Signed Contract _Sivers_PR_EN_250113_FINAL

View original content:https://www.prnewswire.com/news-releases/sivers-semiconductors-signs-chips-act-contracts-with-the-northeast-microelectronics-coalition-hub-302349068.html

SOURCE Sivers Semiconductors

Continue Reading

Technology

iM Global Partner mourns the passing of Philippe Uzan

Published

on

By

PARIS, Jan. 13, 2025 /PRNewswire/ — It is with deep sadness that iM Global Partner (iMGP) announces the passing, one month ago, of our dear friend and colleague, Philippe Uzan.

 

 

Philippe’s exceptional career in asset management spanned more than 30 years and is marked by remarkable achievements in the organizations for which he worked and deep contributions to the industry as a whole. His passing is a tremendous loss to all who knew and worked with him.

Philippe joined iM Global Partner in February 2020 as Deputy CEO and CIO Global Asset Management, responsible for overseeing our financial strategies and products and designing value-added investment solutions for our clients across Europe and the United States.

His expertise spanned all asset classes, and he had a deep understanding of markets and their impact on investors and their investment needs. He was an eloquent man who contributed a number of papers and articles to the media, always with the intention of educating and making financial concepts more relatable. He has left an indelible mark on our organization and on the broader industry.

Prior to joining iM Global Partner, Philippe was latterly Chief Investment Officer at Edmond De Rothschild Asset Management, where he worked for 11 years and where he led the portfolio management teams, optimizing the synergies between analysis and portfolio management. He previously spent three years as Research and Global Asset Allocation Director, where he developed the portfolio management and research teams and modernized investment processes and the product range.

Philippe began his career as an Equity Derivatives Trader at Société Générale and held roles at AGF Asset Management (now part of Allianz Global Investors) and Natixis AM.

Throughout his career, Philippe’s outstanding intelligence, humility, and collaborative spirit earned him the respect and admiration of his peers.

Philippe Couvrecelle, Founder and CEO of iM Global Partner, expressed his heartfelt condolences: “It was with infinite sadness and pain that I learned of Philippe’s passing from a devastating illness. I had known Philippe closely for almost 20 years, as we worked together for Natixis, Edmond de Rothschild and iMGP. I pay immense tribute to his humanity, his sense of humor, his brilliant intelligence and his presence, which I will deeply miss. We had shared so much and still had so much to do together. In his memory, we will continue our path forward with strength, success and intensity, always preserving our values and our company culture to which he was so attached.

We will all miss Philippe enormously at iM Global Partner. He will be remembered not only for his professional achievements but also for his warmth, generosity, kindness and his unwavering dedication to his colleagues and community. Our thoughts are with his wife and three children, his family, friends and loved ones during this difficult time.”

Photo: https://mma.prnewswire.com/media/2595513/iM_Global_Partner.jpg
Logo:  https://mma.prnewswire.com/media/1957526/5110142/iM_Global_Partner_Logo.jpg

CONTACT: media@imgp.com

 

 

View original content:https://www.prnewswire.co.uk/news-releases/im-global-partner-mourns-the-passing-of-philippe-uzan-302348093.html

Continue Reading

Technology

CME Group International Average Daily Volume Reaches Record 7.8 Million Contracts in 2024, Up 14% from 2023

Published

on

By

All-time high ADV for Europe, Middle East & Africa (EMEA), Asia Pacific (APAC) and Canada

LONDON and SINGAPORE, Jan. 13, 2025 /PRNewswire/ — CME Group, the world’s leading derivatives marketplace, today announced that its international average daily volume (ADV) reached a record 7.8 million contracts in 2024, up 14% from 2023. Reflecting all trading reported outside the United States, this was driven by record growth in Energy up 31%, Metals up 27%, Agricultural up 25%, Interest Rate up 12% and Foreign Exchange products up 10% compared to the same period in 2023.

“We were especially pleased to see so many clients outside the U.S. turning to CME Group to access the markets and trade products they needed to navigate through ongoing economic and geopolitical uncertainty last year,” said Julie Winkler, Senior Managing Director and Chief Commercial Officer, CME Group. “Looking ahead, risk management will remain essential in 2025, and we are focused on helping our clients to manage risk and unlock opportunities.”

In 2024, EMEA ADV hit a record 5.8 million contracts, up 17% from 2023. This was driven by new ADV records in Energy up 40%, Agricultural up 31%, Metals up 24%, Interest Rate up 14% and Foreign Exchange products up 12% year on year.

APAC ADV grew to an all-time high of 1.7 million contracts in 2024, up 7% from 2023.  The region saw new ADV records in Agricultural up 16%, as well as Interest Rate and Foreign Exchange products, both up 3%.

Canada ADV achieved a record 164,000 contracts in 2024, with ADV records in Energy, Agricultural and Interest Rate products up 26%, 14% and 10% respectively year on year.

LatAm ADV reached 174,000 contracts in 2024. ADV of Metals and Foreign Exchange products in the region were up 42% and 19%.

Globally, CME Group reported a record ADV of 26.5 million contracts in 2024, up 9% over 2023. This was largely driven by record growth in Interest Rate ADV, up 10% to a record 13.7 million contracts. Metals, Agricultural and Foreign Exchange products also saw record growth, up 23%, 13% and 8% respectively.

As the world’s leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest ratesequity indexesforeign exchangeenergyagricultural products and metals.  The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform.  In addition, it operates one of the world’s leading central counterparty clearing providers, CME Clearing. 

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC (“S&P DJI”). “S&P®”, “S&P 500®”, “SPY®”, “SPX®”, US 500 and The 500 are trademarks of Standard & Poor’s Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners. 

CME-G

View original content:https://www.prnewswire.com/news-releases/cme-group-international-average-daily-volume-reaches-record-7-8-million-contracts-in-2024–up-14-from-2023–302348277.html

SOURCE CME Group

Continue Reading

Trending